Pfizer, Merck may feel pressure from generics

Pfizer Inc. and Merck & Co. are both expected to show the effects of increased competition from generic drugs when the two pharmaceutical bellwethers roll out their third-quarter earnings reports next week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.